Login Preferences
About News Publications Statistics Downloads API Guide License How to use Preferences
bn:00356978n
Noun Concept
SYL
No term available
EN
Teplizumab, sold under the brand name Tzield, is a humanized anti-CD3 monoclonal antibody that is the first approved treatment indicated to delay the onset of stage 3 type 1 diabetes in people with stage 2 T1D. Wikipedia
Relations
Sources
IS A
EN
compound
EN
monoclonal antibody

Please note that, in order to improve your browsing experience on this website, BabelNet® uses various types of cookies, including: browsing functionality, performance and statistical cookies.

By continuing to browse the site you are agreeing to our use of cookies. OK

License